EGFR gene mutations in patients with adenosquamous lung carcinoma.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 24575772)

Published in Asia Pac J Clin Oncol on February 27, 2014

Authors

Tomasz Powrózek1, Paweł Krawczyk, Rodryg Ramlau, Sylwia Sura, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Beata Walczyna, Justyna Szumiło, Katarzyna Szyszka-Barth, Piotr Milecki, Aleksander Barinow-Wojewódzki, Janusz Milanowski

Author Affiliations

1: Pneumonology, Oncology and Allergology Department, Medical University, Lublin, Poland.

Articles by these authors

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet (2011) 11.28

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet (2009) 8.73

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol (2009) 7.80

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol (2006) 7.32

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol (2003) 5.84

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. Lancet Oncol (2011) 5.06

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial. J Clin Oncol (2007) 4.94

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study. Lancet Oncol (2011) 3.24

Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer. J Clin Oncol (2011) 2.69

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. Lancet Oncol (2011) 2.57

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. Lung Cancer (2006) 2.40

Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics (2004) 2.19

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study. Lancet Oncol (2012) 2.09

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol (2008) 1.97

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial. Lung Cancer (2006) 1.75

Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results. J Thorac Oncol (2008) 1.45

Inflammation, cardiometabolic markers and functional changes in a randomized controlled trial of a 12-month exercise program for prostate cancer men. Pol Arch Med Wewn (2017) 1.39

AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study. Cancer (2012) 1.17

Morphology and physiology of the epiphyseal growth plate. Folia Histochem Cytobiol (2009) 1.13

Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Thorac Oncol (2012) 1.07

Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy. J Clin Oncol (2010) 1.03

Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL). J Thorac Oncol (2010) 1.02

Total skin electron irradiation techniques: a review. Postepy Dermatol Alergol (2013) 0.99

Manual defibrillation using paddles--which is the best technique? Resuscitation (2012) 0.96

Ectopic pancreas: endoscopic, ultrasound and radiological features. Folia Morphol (Warsz) (2003) 0.95

89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma. Nucl Med Commun (2007) 0.90

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer. Contemp Oncol (Pozn) (2012) 0.89

Recent advances with topotecan in the treatment of lung cancer. Oncologist (2007) 0.89

A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene (2013) 0.89

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland. Contemp Oncol (Pozn) (2012) 0.88

Prenatal tolerability of acetaminophen and other over-the-counter non-selective cyclooxygenase inhibitors. Pharmacol Rep (2012) 0.87

C-MET inhibitors in the treatment of lung cancer. Curr Treat Options Oncol (2014) 0.87

Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue. Thromb Res (2011) 0.87

Bronchial carcinoid in a 39-year-old man treated for bronchial asthma: a case report. Cases J (2008) 0.86

[DHR brachytherapy as palliative treatment of advanced lung cancer in patients treated previously on another cancer]. Pol Arch Med Wewn (2003) 0.86

[Cyclooxygenase and prostanoids--biological implications]. Postepy Hig Med Dosw (Online) (2006) 0.86

Response of furniture factory workers to work-related airborne allergens. Ann Agric Environ Med (2002) 0.86

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study. J Cancer Res Clin Oncol (2014) 0.85

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients. Oncol Rep (2013) 0.85

Solid-pseudopapillary neoplasm of the pancreas - comparisons between magnetic resonance and histological findings. Pol J Pathol (2013) 0.85

New approaches to linking clinical guidelines to virtual patients. Stud Health Technol Inform (2012) 0.84

Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study. J Thorac Oncol (2014) 0.84

The clinical significance of interleukin 18 assessment in sarcoidosis patients. Respir Med (2006) 0.83

The role of genetic factor in etiopathogenesis of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol (2007) 0.83

Effects of introducing a voluntary virtual patient module to a basic life support with an automated external defibrillator course: a randomised trial. BMC Med Educ (2012) 0.83

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy. Trials (2007) 0.83

Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer. Med Oncol (2014) 0.82

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients. J Cancer Res Clin Oncol (2014) 0.82

The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma. Pathol Oncol Res (2013) 0.82

Occupational exposure to organic dust, microorganisms, endotoxin and peptidoglycan among plants processing workers in Poland. Ann Agric Environ Med (2009) 0.82

A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life. Lung Cancer (2002) 0.81

A phase II randomized study of cisplatin-pemetrexed plus either enzastaurin or placebo in chemonaive patients with advanced non-small cell lung cancer. Oncology (2012) 0.81

The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients. Eur J Cancer Prev (2012) 0.81

Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy. Ann Univ Mariae Curie Sklodowska Med (2003) 0.81

[Malignant peripheral nerve sheath tumor associated with clear cell renal cell carcinoma - case report]. Pneumonol Alergol Pol (2012) 0.81

Sensitive methods for the detection of an insertion in exon 20 of the HER2 gene in the metastasis of non-small cell lung cancer to the central nervous system. Oncol Lett (2013) 0.81

Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report. Med Oncol (2014) 0.80

[Epidemiology and risk factors of the oral carcinoma]. Pol Merkur Lekarski (2012) 0.80

Mouse model of hypersensitivity pneumonitis after inhalation exposure to different microbial antigens associated with organic dusts. Ann Agric Environ Med (2011) 0.80

Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma. Pol Przegl Chir (2012) 0.80

Exposure to airborne microorganisms in furniture factories. Ann Agric Environ Med (2002) 0.80

Polymorphism of the ACE gene and the risk of obstructive sleep apnoea. Pneumonol Alergol Pol (2013) 0.80

The application of real-time PCR technique to detect rare cell clones with primary T790M Substitution of EGFR gene in metastases of non-small cell lung cancer to central nervous system in chemotherapy naive patients. Pathol Oncol Res (2014) 0.80

Chronic obstructive pulmonary disease in farmers and agricultural workers - an overview. Ann Agric Environ Med (2011) 0.79

Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis. Respir Med (2006) 0.79

Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene. Oncol Rep (2013) 0.79

Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD. Ann Agric Environ Med (2009) 0.79

Physical exercise for functional capacity, blood immune function, fatigue, and quality of life in high-risk prostate cancer patients during radiotherapy: a prospective, randomized clinical study. Eur J Phys Rehabil Med (2016) 0.78

The role of opportunistic species of Corynebacterium pseudodiphtheriticum in the pathogenesis of CAP (Community Acquired Pneumonia). Ann Univ Mariae Curie Sklodowska Med (2003) 0.78

Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases. Ginekol Pol (2016) 0.78

Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study. Folia Histochem Cytobiol (2012) 0.78